Our Pipeline
The projects of our four platforms are steadily advancing. The two projects with the fastest progress are ET-01 for severe β-thalassemia and U CAR-T ET-02 for cancer.

The projects of our four platforms are steadily advancing. The two projects with the fastest progress are ET-01 for severe β-thalassemia and U CAR-T ET-02 for cancer.